Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
ArriVent BioPharma, Inc.
Business Segments
Business Segments
Net Income Loss
Net Income Loss
ArriVent BioPharma, Inc.
·
Business Segments
·
1 segment
·
Rolls up to
Net Income
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Business Segments
-$64.39M
-$31.4M
-$34.98M
-$35.54M
-$43.32M
Total
-$64.39M
-$31.4M
-$34.98M
-$35.54M
-$43.32M